Piramal Pharma
- All
- News
- Videos
-
Piramal Enterprises To Demerge And List Pharma Business
Indian conglomerate Piramal Enterprises Ltd (PEL) said on Thursday it was demerging its pharmaceutical business and listing it as a separate entity as part of a move to simplify its corporate structure.
-
Piramal Enterprises Shares Jump After US-Based Carlyle Buys Stake In Pharma Unit
Piramal Pharma Share Price: Piramal Enterprises shares rose to as high as Rs 1,387.55 apiece on the BSE during the session.
-
US-Based Carlyle Buys 20% Stake In Piramal Enterprises' Pharma Business For Rs 3,700 Crore
Piramal Pharma will use the capital raised through the dealto accelerate its organic and inorganic growth plans.
-
Saridon Exempted From List Of Banned Medicines By Top Court, Says Company
Pharma major Piramal Enterprises on Thursday said Saridon, its pain relief tablet, has been exempted from the list of banned fixed dose combinations (FDCs) by the Supreme Court.
-
Piramal To Expand Pharma Vertical Presence In US, Europe
North America and Europe account for over 70 per cent of the company's revenue from pharmaceuticals business.
-
Pharma Stocks Extend Rebound. Should You Buy Now?
HDFC Securities says the Nifty Pharma sub-index of NSE could bounce back up to 9600-9700 levels in next 2-3 months compared to its current value of 9,250.
-
Piramal Enterprises To Demerge Healthcare, Financial Services Businesses
Mr Piramal curtailed his presence in healthcare after he sold erstwhile Piramal Healthcare's domestic formulations division for $3.7 billion to Abbott in 2010.
-
Piramal Enterprises To Acquire 5 Brands From Janssen Pharma
Janssen will continue to sell the products on behalf of Piramal until the marketing authorisations or relevant business relations are transferred to Piramal.
-
Why Morepen Laboratories Shares Are Up 11% Today
Morepen Laboratories shares surged as much as 11per cent on Friday on a report that the Delhi-based pharma company is in talks to sell its OTC (over-the-counter) business.
-
Piramal Enterprises-Pfizer Deal Cleared By Fair Trade Regulator
The Competition Commission of India (CCI) has approved Ajay Piramal-led Piramal Enterprises' proposed acquisition of four brands from pharmaceutical major Pfizer.
-
Government Weighs Relaxing FDI Norms In Brownfield Pharma Companies
Government is considering a proposal to relax foreign direct investment (FDI) norms in existing pharmaceutical companies with a view to attracting more overseas inflows.
-
Court Lifting Ban On FDC Drugs Against Patient Safety: Government
Government on Monday sought vacation of Delhi High Court's interim order staying the ban on some fixed dose combinations (FDC) medicines, saying it would be "against public interest and patient safety" and alleging that the drug firms' sole objective was to make profits.
-
Piramal Eyes Nutrition, Cough-Cold Brands to Boost Consumer Health Arm
Piramal Enterprises Ltd is exploring buying nutritional supplements and cough and cold brands to grow its consumer healthcare business to among the three largest in the country by 2020, a senior executive said.
-
Piramal's Arm to Invest $40 Million in New Technology
Piramal Pharma Solutions is an integrated solutions provider offering comprehensive range of services across the drug lifecycle. With a successful performance record of over four-decade in API supply (active pharmaceutical ingredients), drug products, drug discovery services, and with supply facilities in North America, Europe and Asia, it has esta...
-
Piramal Enterprises Q4 Net Loss at Rs 311 Cr
For the year ended March 31, 2014, the company posted a net loss of Rs 501.41 crore as against that of Rs 227.29 crore in 2012-13.
-
Piramal Enterprises To Demerge And List Pharma Business
Indian conglomerate Piramal Enterprises Ltd (PEL) said on Thursday it was demerging its pharmaceutical business and listing it as a separate entity as part of a move to simplify its corporate structure.
-
Piramal Enterprises Shares Jump After US-Based Carlyle Buys Stake In Pharma Unit
Piramal Pharma Share Price: Piramal Enterprises shares rose to as high as Rs 1,387.55 apiece on the BSE during the session.
-
US-Based Carlyle Buys 20% Stake In Piramal Enterprises' Pharma Business For Rs 3,700 Crore
Piramal Pharma will use the capital raised through the dealto accelerate its organic and inorganic growth plans.
-
Saridon Exempted From List Of Banned Medicines By Top Court, Says Company
Pharma major Piramal Enterprises on Thursday said Saridon, its pain relief tablet, has been exempted from the list of banned fixed dose combinations (FDCs) by the Supreme Court.
-
Piramal To Expand Pharma Vertical Presence In US, Europe
North America and Europe account for over 70 per cent of the company's revenue from pharmaceuticals business.
-
Pharma Stocks Extend Rebound. Should You Buy Now?
HDFC Securities says the Nifty Pharma sub-index of NSE could bounce back up to 9600-9700 levels in next 2-3 months compared to its current value of 9,250.
-
Piramal Enterprises To Demerge Healthcare, Financial Services Businesses
Mr Piramal curtailed his presence in healthcare after he sold erstwhile Piramal Healthcare's domestic formulations division for $3.7 billion to Abbott in 2010.
-
Piramal Enterprises To Acquire 5 Brands From Janssen Pharma
Janssen will continue to sell the products on behalf of Piramal until the marketing authorisations or relevant business relations are transferred to Piramal.
-
Why Morepen Laboratories Shares Are Up 11% Today
Morepen Laboratories shares surged as much as 11per cent on Friday on a report that the Delhi-based pharma company is in talks to sell its OTC (over-the-counter) business.
-
Piramal Enterprises-Pfizer Deal Cleared By Fair Trade Regulator
The Competition Commission of India (CCI) has approved Ajay Piramal-led Piramal Enterprises' proposed acquisition of four brands from pharmaceutical major Pfizer.
-
Government Weighs Relaxing FDI Norms In Brownfield Pharma Companies
Government is considering a proposal to relax foreign direct investment (FDI) norms in existing pharmaceutical companies with a view to attracting more overseas inflows.
-
Court Lifting Ban On FDC Drugs Against Patient Safety: Government
Government on Monday sought vacation of Delhi High Court's interim order staying the ban on some fixed dose combinations (FDC) medicines, saying it would be "against public interest and patient safety" and alleging that the drug firms' sole objective was to make profits.
-
Piramal Eyes Nutrition, Cough-Cold Brands to Boost Consumer Health Arm
Piramal Enterprises Ltd is exploring buying nutritional supplements and cough and cold brands to grow its consumer healthcare business to among the three largest in the country by 2020, a senior executive said.
-
Piramal's Arm to Invest $40 Million in New Technology
Piramal Pharma Solutions is an integrated solutions provider offering comprehensive range of services across the drug lifecycle. With a successful performance record of over four-decade in API supply (active pharmaceutical ingredients), drug products, drug discovery services, and with supply facilities in North America, Europe and Asia, it has esta...
-
Piramal Enterprises Q4 Net Loss at Rs 311 Cr
For the year ended March 31, 2014, the company posted a net loss of Rs 501.41 crore as against that of Rs 227.29 crore in 2012-13.
